x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

AI For Pharma Growth

Dr Andree Bates

AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets to

technology

All Episodes

27:22

E107 | Navigating Governance, Risk, and the AI Landscape

AI For Pharma Growth ·

2024/04/02

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Henz, Head of Governance Risk and Compliance at Primetals Technologies USA. In this episode, Andree and Patrick discuss the relevance and implementation of AI in compliance and risk. They explore the ethics and complexities of this practice by individuals and big corporations, as well as the responsibilities of those using generative AI, which is becoming increasingly autonomous. Addressing the key issues of machine

en

29:11

E106 | How AI is preventing maternal and fetal death...

AI For Pharma Growth ·

2024/03/27

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr Michelle Oyen, Associate Professor of Biomedical Engineering at Washington University in St.Louis. Michelle discusses the use and importance of AI in the field of maternal and fetal health. When an unexpected source changes Michelle’s career trajectory, she used her engineering background to research computational models to gather information related to pregnancy and childbirth. Michelle and her team have looked into all

en

44:43

E105 | Are we already at the point of human–computer...

AI For Pharma Growth ·

2024/03/20

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Hon Weng Chong, M.D., the founder of Cortical Labs. They discuss the inception of Cortical Labs and how the company is responsible for the creation of DishBrain, a powerful computational neuron system using human brain cells. Eventually, this cellular neuron system became so adaptive and responsive, it learned how to play the classic video game Pong. Beginning with the use of mouse brain cells, the development and implementation

en

28:05

E104 | How pharma can use AI for content compliance...

AI For Pharma Growth ·

2024/03/13

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Glinski and Ryan Brotman, the co-founders of Composehealth.ai. They discuss the use of artificial intelligence to automate the creation of an accurate content compliance review process, ready for use by individuals and businesses. Compose Health is an AI platform that gives its users a precise method of drafting and generating pharma content that is suitable for mandatory compliance laws. Their platform facilitates the

en

29:30

E103 | Using AI for cutting IND application time

AI For Pharma Growth ·

2024/03/06

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Ari Caroline, CEO of Weave Bio, to discuss how the company is using artificial intelligence to streamline the IND application process for new therapeutics. Weave Bio has developed an AI-powered platform that aims to cut the typical four month IND drafting time in half by automatically generating initial drafts of IND applications using supporting data and reports provided by users. The platform also helps organise data rooms,

en

27:24

E102 | How AI is being leveraged for addiction

AI For Pharma Growth ·

2024/02/28

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Manny Nsien, MHA the CEO of Ripple Ranch, an addiction treatment centre located in Texas. They talk about how artificial intelligence can be leveraged to more precisely diagnose those suffering from addiction earlier by analysing various streams of patient data, including information from medical records, wearable devices, genetics testing, and more. Additionally, they discuss how AI is being applied to personalise addiction

en

28:51

E101 | Marketing in the Age of AI

AI For Pharma Growth ·

2024/02/21

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Emanuel Rose to talk about Authentic Marketing in the Age of AI. You will learn how 51% of marketers are now using AI and various ways it's being used, including for copywriting, creative support, and data analysis. Emanuel discusses using AI in marketing while maintaining authenticity and emphasising brand voice, content calendars, and human input. Common mistakes like overreliance on AI without editing are covered. The

en

37:34

E100 | How Pharma can manage risk with cybersecurity...

AI For Pharma Growth ·

2024/02/14

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Greg Woolf of AI Think Tank to discuss managing cybersecurity risks with AI in the pharmaceutical industry. Greg draws from his experience launching AI companies to discuss the growing $10 trillion cybercrime industry. He addressed threats facing healthcare like ransomware and identity theft exploiting medical data breaches. Greg also covers challenges of reliability, bias and other risks with AI systems. However, he believes AI

en

37:30

E99 | How to use AI to connect meaningfully with...

AI For Pharma Growth ·

2024/02/07

In this episode of AI For Pharma Growth, Dr Andree Bates discusses SQREEM Technologies with Ian Chapman-Banks. SQREEM uses AI to analyse digital behaviours of healthcare professionals, helping pharmaceutical companies better engage this audience. SQREEM has developed advanced algorithms and one of the largest datasets on probabilistic healthcare professional profiles globally. The discussion provides insights into how SQREEM personalised marketing and ad targeting for professional segments. It

en

01:11:34

E98 | How to Use Generative AI models effectively for...

AI For Pharma Growth ·

2024/01/31

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jonathan Green who is an expert at using artificial intelligence tools to accelerate online business. He is the Best Selling Author of chat GPT Profits, and has a mailing list of over 100,000 subscribers. They talk about how generative AI is revolutionising digital marketing and how it can be used for tasks like content creation, data analysis, and customer engagement. Jonathan discusses how he uses AI tools like chatGPT,

en

44:10

E97 | Predictions about the future of Tech

AI For Pharma Growth ·

2024/01/24

In this episode of AI For Pharma Growth, host Dr Andree Bates interviews Sani Abdul-Jabbar, CEO of VezTek USA, a technology consulting firm. He has over 20 years of experience helping startups bring emerging technologies like AI and blockchain to market faster. He discusses his background and how VezTek supports clients. Sani also shares his insights on recent advancements in machine learning and blockchain, as well as predictions for industries like healthcare, fintech and beyond. In this

en

38:14

E96 | How Generative AI and Web3.0 are...

AI For Pharma Growth ·

2024/01/17

In this episode of AI For Pharma Growth, host Dr Andree Bates talks with Eric McHugh, president of SHOPX, to discuss opportunities at the intersection of generative AI and web3 for pharmaceutical companies. Eric explains how blockchain technologies like non-fungible tokens (NFTs) can help authenticate drugs and medical records to prevent counterfeiting. He also explores how patient data on the blockchain could help AI systems identify new treatment patterns and target drug development. Eric shares

en

41:30

E95 | How pharma R&D can use AI to accelerate...

AI For Pharma Growth ·

2024/01/10

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Casper Wilstrup, founder and CEO of Abzu. They discuss how Abzu's QLattice Explainable AI algorithm can be used to accelerate disease understanding, drug design, and insights in pharma R&D. Casper explains how the QLattice generates hypotheses to explain phenomena using symbolic AI without requiring large datasets. They explore applications in areas like biomarkers, RNA therapeutics, and reducing drug development timelines

en

24:35

E94 | AI for forecasting

AI For Pharma Growth ·

2024/01/03

In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Piet Buyck, CEO and founder of Garvis AI. He talks about how the company's AI system provides significantly more accurate demand forecasting for pharmaceutical companies. Piet explains that Garvis AI leverages different data sources and AI techniques to separately forecast demand for various elements, reducing errors by up to 30% compared to traditional methods. In this episode you will learn: How traditional pharmaceutical

en

42:23

E93 | How to hyperscale your business with enterprise...

AI For Pharma Growth ·

2023/12/27

Dr. Andree Bates interviewed Alexander De Ridder, co-founder and CTO of SmythOS, to discuss how their AI agent platform can help pharmaceutical companies scale up their businesses. Alexander explained that SmythOS allows users to orchestrate intelligent agents that can automate workflows, analyse complex datasets, and augment human work. The agents can collaborate to complete tasks like research, writing, and marketing. By tapping into available AI models and APIs, the agents are able to apply

en

21:08

E92 | How pharma can use AI to do hours worth of...

AI For Pharma Growth ·

2023/12/20

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Saikiran Chandha, founder of SciSpace. Saikiran discusses how SciSpace uses AI to help researchers save time on literature reviews and writing. SciSpace has developed tools using large language models to summarise papers, generate citations, and paraphrase text while maintaining the desired tone. Saikiran explains how researchers can upload their own papers and use SciSpace's AI capabilities on the full text. The discussion

en

17:33

E91 | The state of Ai in biopharma R&D, BD&L and...

AI For Pharma Growth ·

2023/12/13

In this episode of AI For Pharma Growth, Dr Andree Bates talks about the state of AI in biopharma, with a specific focus on how it is being applied across the value chain from research and development to business development, licensing, and clinical trials. She discusses how AI can help accelerate drug discovery by analysing vast amounts of data, generate new drug candidates through machine learning, and help design and optimise clinical trials. Real-world examples of AI being used for COVID drug

en

26:37

E90 | How to use AI to redesign drugs to be faster,...

AI For Pharma Growth ·

2023/12/06

In this episode of AI For Pharma Growth, Dr Andree Bates interviews Alice Yu and Mena Abdelsayed, co-founders of OncoCardia. They discuss how their company uses artificial intelligence and stem cell technology to redesign drugs to be safer and more effective. They aim to reduce the time it takes to develop new drugs from almost a decade to just days or weeks. OncoCardia leverages AI to predict safer drug analogues and their synthesis routes. Their stem cell platform also allows for high

en

24:45

E89 | How to Use AI quickly to engage HCPs and patients

AI For Pharma Growth ·

2023/11/29

In this episode of AI For Pharma Growth Dr Andree Bates is joined by Mark Benthin, Founder, CEO and Executive Chairman of ViiHealth to discuss how AI can be used to quickly engage HCPs and patients through personalising interactions with marketing content. Mark discusses ViiHealth's use of generative AI to create personalised videos for physicians and patients using just one hour of recorded content from the person. He explains how this approach increases engagement rates, click through rates, and

en

30:43

E88 | AI in healthcare policy

AI For Pharma Growth ·

2023/11/22

In this episode of AI For Pharma Growth, host Dr. Andree Bates is joined by guest Dylan Reid, a Legislative Associate focused on health policy. Dylan discusses the current state of AI healthcare policy across various US government organisations. He outlines the FDA approval process, initiatives and committees aimed at balancing innovation and oversight. Additionally, Dylan shares his views on using AI to improve outcomes, particularly in states facing greater challenges. In this episode you will

en

209 results

Similar Podcasts

Lead With AI

Tamara Nall

Linux in the Ham Shack

Black Sparrow Media

Data Engineering Podcast

Tobias Macey

Eye On A.I.

Craig S. Smith

Reflections

Livewire Labs